THX Pharma and Biocodex have entered into a strategic licensing agreement to further the development of two drug candidates, ...

Insilico Medicine has announced several AI drug discovery collaborations with CMS across several projects in CNS and ...

Early-phase oncology trials carry substantial scientific and commercial risk in cancer drug development. Getting them right ...

RWD and RWE are reshaping the design of clinical trials, making them smarter, faster, and more efficient. Read more here: ...

Under the deal, AbbVie agreed to lower prices on certain Medicaid drugs and expand distribution via the TrumpRx direct-to-patient platform.

AstraZeneca’s cancer medicine sales rose 14% in 2025, with upcoming disease expansions a foundation for further growth in 2026.

Takeda has entered into a multi-year partnership to utilise Iambic’s AI drug discovery models for advancing small molecule ...

Novo and Hims & Hers have continually locked horns over the legality of obesity drug offerings. Hims & Hers has abandoned ...

REGENXBIO has received a CRL from the US FDA related to its BLA for RGX-121 to treat MPS II, also called hunter syndrome.

Innovent Biologics and Eli Lilly and Company have entered into a strategic collaboration agreement to accelerate the global ...

After more than a year out in the cold, the programme’s reauthorisation is a boost for rare disease therapy developers.

CEPI and Samsung Biologics have partnered in an outbreak-ready vaccine manufacturing partnership to enhance the preparedness ...